SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-002624
Filing Date
2021-01-11
Accepted
2021-01-11 06:04:42
Documents
14
Period of Report
2021-01-11
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm212700d1_8k.htm   iXBRL 8-K 26448
2 EXHIBIT 99.1 tm212700d1_ex99-1.htm EX-99.1 12139
6 GRAPHIC tm212700d1_ex99-1img01.jpg GRAPHIC 3052
  Complete submission text file 0001104659-21-002624.txt   221679

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA idra-20210111.xsd EX-101.SCH 3196
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE idra-20210111_lab.xml EX-101.LAB 34592
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idra-20210111_pre.xml EX-101.PRE 22717
7 EXTRACTED XBRL INSTANCE DOCUMENT tm212700d1_8k_htm.xml XML 3611
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31918 | Film No.: 21518986
SIC: 2836 Biological Products, (No Diagnostic Substances)